RBOT Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 0.94
- P/S (TTM)
- —
- EV/EBITDA
- 24.74
Profitability & growth
- ROE (TTM)
- -177.5%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 1.82
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Vicarious Surgical Inc.
Company profileVicarious Surgical Inc. (RBOT) is a cutting-edge medical technology company revolutionizing surgical practices with its advanced robotic surgical systems designed to enhance precision and improve patient outcomes. By leveraging a proprietary platform that integrates advanced robotics and artificial intelligence, the company is at the forefront of the minimally invasive surgery movement, equipping surgeons with unmatched dexterity, visualization, and control. Vicarious Surgical not only aims to boost surgical efficiency but also to significantly reduce patient recovery times, addressing the…
Classification
- Sector
- Healthcare
- Industry
- Medical Devices
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 78 FOURTH AVENUE, WALTHAM, MA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer